Base de dados : MEDLINE
Pesquisa : D26.776.708.822 [Categoria DeCS]
Referências encontradas : 4539 [refinar]
Mostrando: 1 .. 10   no formato [Detalhado]

página 1 de 454 ir para página                         

  1 / 4539 MEDLINE  
              next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29489686
[Au] Autor:Shi X; Yu S; Wang F; Zhao Q; Xu H; Li B
[Ad] Endereço:Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University.
[Ti] Título:A gastrointestinal stromal tumor with acute bleeding: Management and nursing.
[So] Source:Medicine (Baltimore);97(9):e9874, 2018 Mar.
[Is] ISSN:1536-5964
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:RATIONALE: Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors involving the gastrointestinal tract. A small percentage of GISTs may cause acute gastrointestinal bleeding, which requires urgent surgical intervention. PATIENT CONCERNS: In this case report, we present a 62-year-old male patient with who was hospitalized due to acute bleeding. DIAGNOSES: The patient was diagnosed as GIST with low risk. INTERVENTIONS: The patient was treated endoscopically with polidocanol sclerotherapy. OUTCOMES: The mass was removed completely, and the patient was discharged at day 9 after operation. LESSONS: This case indicates that GIST can present as massive upper gastrointestinal bleeding and urgent endoscopic sclerotherapy can be life-saving. The endoscopical intervention may be a good alternative for emergency.
[Mh] Termos MeSH primário: Hemorragia Gastrointestinal/etiologia
Neoplasias Gastrointestinais/complicações
Tumores do Estroma Gastrointestinal/complicações
[Mh] Termos MeSH secundário: Hemorragia Gastrointestinal/terapia
Neoplasias Gastrointestinais/terapia
Tumores do Estroma Gastrointestinal/terapia
Seres Humanos
Masculino
Meia-Idade
Polietilenoglicóis/uso terapêutico
Soluções Esclerosantes/uso terapêutico
Escleroterapia/métodos
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Sclerosing Solutions); 0AWH8BFG9A (polidocanol); 30IQX730WE (Polyethylene Glycols)
[Em] Mês de entrada:1803
[Cu] Atualização por classe:180307
[Lr] Data última revisão:
180307
[Sb] Subgrupo de revista:AIM; IM
[Da] Data de entrada para processamento:180301
[St] Status:MEDLINE
[do] DOI:10.1097/MD.0000000000009874


  2 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:29173136
[Au] Autor:Bai T; Chen Y; Jiang W; Yan F; Fan Y
[Ad] Endereço:1 Department of Applied Mechanics, Sichuan University, Chengdu, China.
[Ti] Título:Studies on Foam Decay Trend and Influence of Temperature Jump on Foam Stability in Sclerotherapy.
[So] Source:Vasc Endovascular Surg;52(2):98-106, 2018 Feb.
[Is] ISSN:1938-9116
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:OBJECTIVES: This study investigated the influence of temperature jump and liquid-gas ratio on foam stability to derive the foam-decay law. METHODS: The experimental group conditions were as follows: mutation temperatures (10°C, 16°C, 20°C, 23°C, 25°C, and 27°C to >37°C) and liquid-gas ratios (1:1, 1:2, 1:3, and 1:4). The control group conditions were as follows: temperatures (10°C, 16°C, 20°C, 23°C, 25°C and 27°C) and liquid-gas ratios (1:1, 1:2, 1:3, and 1:4). A homemade device manufactured using the Tessari DSS method was used to prepare the foam. The decay process was videotape recorded. In the drainage rate curve, the temperature rose, and the liquid-gas ratio varied from 1:1 to 1:4, causing faster decay. RESULTS: In the entire process, the foam volume decreased with increasing drainage rate. The relationships were almost linear. Comparison of the experimental and control groups shows that the temperature jump results in a drainage time range of 1 to 15 seconds. The half-life ranges from 10 to 30 seconds. The maximum rate is 18.85%. Changes in the preparation temperature yields a drainage time range of 3 to 30 seconds. The half-life varies from 20 to 60 seconds. CONCLUSION: Decreasing the temperature jump range and liquid-gas ratio gradually enhances the foam stability. The foam decay time and drainage rate exhibit an exponential function distribution.
[Mh] Termos MeSH primário: Soluções Esclerosantes/química
Escleroterapia/métodos
Morruato de Sódio/química
Temperatura Ambiente
[Mh] Termos MeSH secundário: Estabilidade de Medicamentos
Meia-Vida
Modelos Lineares
Modelos Químicos
Transição de Fase
Fatores de Tempo
Gravação em Vídeo
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Sclerosing Solutions); 8031-09-2 (Sodium Morrhuate)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180228
[Lr] Data última revisão:
180228
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:171128
[St] Status:MEDLINE
[do] DOI:10.1177/1538574417741786


  3 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28746255
[Au] Autor:Hirabayashi KE; Kalin-Hajdu E; Bever GJ; Vagefi MR; de Alba Campomanes AG; Cooke DL; Dowd CF; Kersten RC
[Ti] Título:Normalization of Congenital Venous Stasis Retinopathy Following Sclerotherapy of a Macrocystic Lymphatic Malformation.
[So] Source:Ophthal Plast Reconstr Surg;34(1):e19-e21, 2018 Jan/Feb.
[Is] ISSN:1537-2677
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The authors describe, for the first time to their knowledge, a case of a congenital macrocystic lymphatic malformation of the orbit with associated venous stasis retinopathy that acutely normalized after drainage and sclerotherapy of the lesion. Prenatal ultrasound revealed prominence of the left orbital soft tissue, and at birth, the patient was noted to have unilateral proptosis, tortuous retinal vessels, and intraretinal hemorrhages in all 4 quadrants in the left eye. MRI demonstrated a primarily intraconal, multiloculated, T2-hyperintense mass consistent with a lymphatic malformation. Ultrasound-guided cyst aspiration and sclerotherapy was performed, with subsequent improvement of the proptosis and resolution of the vessel tortuosity and intraretinal hemorrhages. Although venous stasis retinopathy is usually related to central retinal vein occlusion or carotid artery occlusive disease, any entity that increases orbital venous resistance can generate retinal venous dilation and intraretinal hemorrhages, including an orbital lymphatic malformation.
[Mh] Termos MeSH primário: Anormalidades Linfáticas/tratamento farmacológico
Doenças Orbitárias/tratamento farmacológico
Recuperação de Função Fisiológica
Doenças Retinianas/induzido quimicamente
Veia Retiniana/fisiopatologia
Soluções Esclerosantes/efeitos adversos
Escleroterapia/efeitos adversos
[Mh] Termos MeSH secundário: Dexametasona/administração & dosagem
Feminino
Seguimentos
Glucocorticoides/administração & dosagem
Seres Humanos
Recém-Nascido
Injeções Intravenosas
Anormalidades Linfáticas/diagnóstico
Anormalidades Linfáticas/cirurgia
Imagem por Ressonância Magnética
Doenças Orbitárias/congênito
Doenças Orbitárias/cirurgia
Paracentese/métodos
Fluxo Sanguíneo Regional/fisiologia
Doenças Retinianas/diagnóstico
Doenças Retinianas/tratamento farmacológico
Cirurgia Assistida por Computador/métodos
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; RESEARCH SUPPORT, NON-U.S. GOV'T
[Nm] Nome de substância:
0 (Glucocorticoids); 0 (Sclerosing Solutions); 7S5I7G3JQL (Dexamethasone)
[Em] Mês de entrada:1802
[Cu] Atualização por classe:180219
[Lr] Data última revisão:
180219
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170727
[St] Status:MEDLINE
[do] DOI:10.1097/IOP.0000000000000975


  4 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo SciELO Brasil
[PMID]:28954096
[Au] Autor:AlGhamdi KM; Kumar A; Ashour AE; Al-Rikabi AC; AlOmrani AH; Ahamed SS
[Ad] Endereço:Dermatology Department, College of Medicine, King Saud University - Riyadh, Saudi Arabia.
[Ti] Título:Vascular sclerosing effects of bleomycin on cutaneous veins: a pharmacopathologic study on experimental animals.
[So] Source:An Bras Dermatol;92(4):484-491, 2017 Jul-Aug.
[Is] ISSN:1806-4841
[Cp] País de publicação:Brazil
[La] Idioma:eng
[Ab] Resumo:Background:: Varicose veins and the complications of venous disease are common disorders in humans. Objective:: To study the effects of bleomycin as a potential new sclerosing agent and its adverse events in treating varicose veins. Methods:: Bleomycin-loaded liposomes 0.1ml was injected in the dorsal ear veins of white New Zealand rabbits. Sodium tetradecyl sulfate was used as a positive control. Normal saline was used as negative control. The blood vessels of the treated ears were photographed before and at one hour and two, eight and 45 days after treatment. Biopsies from the treated areas were obtained for histological examination. Blood samples were collected to determine any possible toxicity. Results:: Bleomycin by itself was ineffective; therefore, liposomes were used as a vector to deliver bleomycin to the vein lumen. Subsequently, bleomycin started showing its sclerosing effects. Toxicity monitoring showed no apparent hematologic, pulmonary, hepatic or renal toxicities. This study revealed that bleomycin induced vasculitis, which led to vascular occlusion, which was observed on day 1 and day 8. No bleomycin-related injury was noted by histopathological examination of lung sections. The calculation of the lung/body weight coefficient indicated that edema was present in the experimental groups compared with the negative and positive controls. Study limitations:: Relatively small number of experimental animals used. Conclusions:: This study showed that bleomycin-loaded liposomes were able to induce vasculitis and vascular occlusion without any toxicity or complications. It might be useful, hence, to treat patients suffering from Varicose veins and other ectatic vascular diseases with this agent.
[Mh] Termos MeSH primário: Antibióticos Antineoplásicos/administração & dosagem
Bleomicina/farmacologia
Soluções Esclerosantes/farmacologia
Escleroterapia/métodos
Tetradecilsulfato de Sódio/administração & dosagem
Varizes/terapia
[Mh] Termos MeSH secundário: Animais
Bleomicina/administração & dosagem
Modelos Animais de Doenças
Avaliação Pré-Clínica de Medicamentos
Injeções Intravenosas
Lipossomos
Coelhos
Soluções Esclerosantes/administração & dosagem
Soluções Esclerosantes/efeitos adversos
Vasculite/induzido quimicamente
Vasculite/tratamento farmacológico
Veias/efeitos dos fármacos
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Antibiotics, Antineoplastic); 0 (Liposomes); 0 (Sclerosing Solutions); 11056-06-7 (Bleomycin); Q1SUG5KBD6 (Sodium Tetradecyl Sulfate)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171010
[Lr] Data última revisão:
171010
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170928
[St] Status:MEDLINE


  5 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28430735
[Au] Autor:Jenkinson HA; Wilmas KM; Silapunt S
[Ad] Endereço:*University of Texas McGovern Medical School at Houston, Houston, Texas; †Department of Dermatology, University of Texas McGovern Medical School at Houston, Houston, Texas.
[Ti] Título:Sodium Tetradecyl Sulfate: A Review of Clinical Uses.
[So] Source:Dermatol Surg;43(11):1313-1320, 2017 Nov.
[Is] ISSN:1524-4725
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: Sodium tetradecyl sulfate (STS) is Food and Drug Administration approved for treatment of varicose veins, but numerous other off-label applications have been reported. OBJECTIVE: To describe the clinical uses of STS, as well as efficacy and adverse effects. METHODS: Review of studies searchable on PubMed from 1938 to 2016 describing clinical uses of STS to determine efficacy and adverse effects associated with various applications. RESULTS: Sodium tetradecyl sulfate has shown efficacy in the treatment of varicose veins, telangiectasias, hemangioma, pyogenic granuloma, cherry angioma, Kaposi sarcoma, lymphangioma circumscriptum, digital mucous cyst, ganglion cyst, glomangioma, angiokeratoma of Fordyce, pseudocyst of the auricle, and verruca. Commonly reported side effects include pain, erythema, swelling, hyperpigmentation, telangiectatic matting, and ulceration. Serious side effects such as anaphylaxis, pulmonary embolism, stroke, and myocardial infarction have also been reported. Most sources were case reports and small prospective studies, as such the strength of data supporting many uses is limited by small sample sizes and lack of controls. CONCLUSION: Although not always the most effective method of treatment in off-label usage, use of STS has been frequently selected for a variety of applications for reasons of simplicity, low cost, lack of availability of technologically advanced equipment, and intricacies related to anatomic location.
[Mh] Termos MeSH primário: Uso Off-Label
Soluções Esclerosantes/uso terapêutico
Tetradecilsulfato de Sódio/uso terapêutico
Tensoativos/uso terapêutico
[Mh] Termos MeSH secundário: Seres Humanos
Soluções Esclerosantes/efeitos adversos
Tetradecilsulfato de Sódio/efeitos adversos
Tensoativos/efeitos adversos
Varizes/tratamento farmacológico
[Pt] Tipo de publicação:JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Sclerosing Solutions); 0 (Surface-Active Agents); Q1SUG5KBD6 (Sodium Tetradecyl Sulfate)
[Em] Mês de entrada:1710
[Cu] Atualização por classe:171027
[Lr] Data última revisão:
171027
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170422
[St] Status:MEDLINE
[do] DOI:10.1097/DSS.0000000000001143


  6 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28390757
[Au] Autor:Chen AW; Wang T; Huang YY; Liu SH
[Ad] Endereço:Attending Staff, Department of Oral and Maxillofacial Surgery, Qilu Hospital and the Institute of Stomatology, Shandong University, Jinan, China.
[Ti] Título:Multistage Sclerotherapy for Extensive Lymphatic Malformations With Airway Involvement in Infant: A Protocol to Prevent Tracheotomy.
[So] Source:J Oral Maxillofac Surg;75(9):1882-1890, 2017 Sep.
[Is] ISSN:1531-5053
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:PURPOSE: The management of extensive head and neck lymphatic malformations (LMs) in infants is challenging because of life-threatening upper airway compression. The aim of this study was to present a management protocol and evaluate the clinical outcomes for preventing tracheotomy in these patients. MATERIALS AND METHODS: Fifteen infants with extensive head and neck LMs and airway involvement were enrolled from August 2010 through September 2015 at the Qilu Hospital of Shandong University (Jinan, China). According to various key factors associated with airway compression of patients in the perioperative period, different anesthesia types, treatment times, sclerosant concentrations, and sclerotherapy protocols were used. Multistage sclerotherapy was performed with bleomycin A5. All patients were followed at 1, 3, 6, and 12 months. More extended follow-up was offered if patients had a residual lesion requiring supplementary sclerotherapy. Reviews on the site and size of the lesion, times and durations of treatments, therapeutic response, airway complications, and conduction of tracheotomy were performed. RESULTS: LM lesions in the head and neck were located in the floor of the mouth, tongue, and neck. An overall average of 5 treatments was required; a lesion volume decrease of more than 50% was achieved in all patients. For efficacy, morphologic resolution was achieved in 3 of 15 cases (20%), and there was a substantial response in 12 of 15 cases (80%). Eight of 15 patients (53.3%) with microcystic LMs exhibited immediate swelling and had more serious upper airway symptoms than preoperatively, and 2 of 15 patients (13.3%) had feeding difficulty. No upper airway obstruction occurred and no tracheotomy was performed in the patients in this study. CONCLUSIONS: Multistage sclerotherapy with bleomycin A5 is a safe and effective treatment for extensive head and neck LMs in infants with airway involvement. A routine perioperative protocol is essential for decreasing airway complications.
[Mh] Termos MeSH primário: Obstrução das Vias Respiratórias/terapia
Anormalidades Linfáticas/terapia
Soluções Esclerosantes/uso terapêutico
Escleroterapia/métodos
[Mh] Termos MeSH secundário: Obstrução das Vias Respiratórias/etiologia
Anestésicos Locais/uso terapêutico
Antibióticos Antineoplásicos/uso terapêutico
Bleomicina/uso terapêutico
Dexametasona/uso terapêutico
Quimioterapia Combinada
Feminino
Glucocorticoides/uso terapêutico
Cabeça/patologia
Seres Humanos
Lactente
Recém-Nascido
Lidocaína/uso terapêutico
Anormalidades Linfáticas/complicações
Imagem por Ressonância Magnética
Masculino
Pescoço/patologia
Estudos Retrospectivos
Resultado do Tratamento
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Anesthetics, Local); 0 (Antibiotics, Antineoplastic); 0 (Glucocorticoids); 0 (Sclerosing Solutions); 11056-06-7 (Bleomycin); 7S5I7G3JQL (Dexamethasone); 98PI200987 (Lidocaine)
[Em] Mês de entrada:1709
[Cu] Atualização por classe:170920
[Lr] Data última revisão:
170920
[Sb] Subgrupo de revista:AIM; D; IM
[Da] Data de entrada para processamento:170410
[St] Status:MEDLINE


  7 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
[PMID]:28358710
[Au] Autor:Patel KC; Kalantzis G; El-Hindy N; Chang BY
[Ad] Endereço:Department of Ophthalmology, Huddersfield Royal Infirmary, Huddersfield, U.K. karnesh@doctors.org.uk.
[Ti] Título:Sclerotherapy for Orbital Lymphangioma - Case Series and Literature Review.
[So] Source:In Vivo;31(2):263-266, 2017 Mar-Apr.
[Is] ISSN:1791-7549
[Cp] País de publicação:Greece
[La] Idioma:eng
[Ab] Resumo:Orbital lymphangioma is a lymphatic system lesion that commonly presents in childhood. Management of these lesions is complex. Sclerotherapy is a therapy used to treat and shrink lesions prior to or as an alternative to surgery. We present three cases of orbital lymphangioma that were treated with sclerotherapy. Case 1: A 6-month-old boy was presented in 2010 with right ptosis and proptosis. Magnetic resonance imaging (MRI) identified a lesion involving the right orbit and face. Case 2: A 3-year-old girl was presented in 2011 with intermittent right periorbital swelling and medial canthal bleeding. MRI identified a soft-tissue lesion in the right orbit, extending into the face. Case 3: A 3-year-old girl was presented in 2012 with vomiting, and painful right proptosis. MRI identified an intra-conal lesion in the right orbit with fluid filled levels. All three patients were treated with sclerotherapy (sodium tetradecylsulfate). Sclerotherapy is a promising treatment for orbital lymphangioma. Its use may prevent the need for, or minimise the amount of surgical management. Several sclerosants are now commonly used to treat these lesions.
[Mh] Termos MeSH primário: Linfangioma/terapia
Neoplasias Orbitárias/terapia
Escleroterapia/métodos
[Mh] Termos MeSH secundário: Pré-Escolar
Feminino
Seres Humanos
Lactente
Linfangioma/diagnóstico por imagem
Imagem por Ressonância Magnética
Masculino
Órbita/diagnóstico por imagem
Órbita/patologia
Neoplasias Orbitárias/diagnóstico por imagem
Soluções Esclerosantes/uso terapêutico
Tetradecilsulfato de Sódio/uso terapêutico
Resultado do Tratamento
[Pt] Tipo de publicação:CASE REPORTS; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Sclerosing Solutions); Q1SUG5KBD6 (Sodium Tetradecyl Sulfate)
[Em] Mês de entrada:1706
[Cu] Atualização por classe:170601
[Lr] Data última revisão:
170601
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170331
[St] Status:MEDLINE


  8 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28272085
[Au] Autor:Lam C; Billingsley EM
[Ad] Endereço:Department of Dermatology, Penn State College of Medicine, The Milton S. Hershey Medical Center, Hershey, Pennsylvania.
[Ti] Título:Nasopharyngeal Swab Applicator for Chemical Matricectomy.
[So] Source:Dermatol Surg;43(11):1400-1401, 2017 11.
[Is] ISSN:1524-4725
[Cp] País de publicação:United States
[La] Idioma:eng
[Mh] Termos MeSH primário: Alginatos/administração & dosagem
Hemostáticos/administração & dosagem
Unhas Encravadas/cirurgia
Procedimentos Cirúrgicos Otorrinolaringológicos/instrumentação
Fenol/administração & dosagem
Soluções Esclerosantes/administração & dosagem
[Mh] Termos MeSH secundário: Ácido Glucurônico/administração & dosagem
Ácidos Hexurônicos/administração & dosagem
Seres Humanos
Nasofaringe
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Alginates); 0 (Hemostatics); 0 (Hexuronic Acids); 0 (Sclerosing Solutions); 339NCG44TV (Phenol); 8A5D83Q4RW (Glucuronic Acid); 8C3Z4148WZ (alginic acid)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171113
[Lr] Data última revisão:
171113
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170309
[St] Status:MEDLINE
[do] DOI:10.1097/DSS.0000000000001102


  9 / 4539 MEDLINE  
              first record previous record next record last record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28267008
[Au] Autor:Gecim IE; Goktug UU; Celasin H
[Ad] Endereço:1 Department of General Surgery, Ankara University Medical School, Ankara, Turkey 2 General Surgery Clinic, Akay Hastanesi, Ankara, Turkey.
[Ti] Título:Endoscopic Pilonidal Sinus Treatment Combined With Crystalized Phenol Application May Prevent Recurrence.
[So] Source:Dis Colon Rectum;60(4):405-407, 2017 Apr.
[Is] ISSN:1530-0358
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:BACKGROUND: No single treatment yet exists for pilonidal disease that has a short healing time, good cosmetic results, and a low rate of recurrence. Phenol crystal application and diathermy ablation through an endoscope have been used for the treatment of pilonidal disease, but this cohort is the first one to combine them. OBJECTIVE: The purpose of this study was to examine the safety, effectiveness, and short- and long-term outcomes of crystalized phenol treatment combined with endoscopic pilonidal sinus treatment for pilonidal disease. DESIGN: This was a prospective cohort study. SETTINGS: Procedures were performed in 2 hospitals by the same surgeon between February and July 2014. PATIENTS: Twenty-three patients underwent surgical treatment for pilonidal disease. INTERVENTIONS: Under local anesthesia and sedation, all of the patients underwent a video-assisted diathermy ablation of the sinus cavity and the application of phenol crystals. MAIN OUTCOME MEASURES: Adverse events were recorded as a measure of safety and tolerability. Failure to heal and recurrence rate were documented and evaluated. RESULTS: Patients were discharged on the same day as surgery. There was no or minimal postoperative pain (mean visual analog scale score, 1.40 ± 0.95). Mean operation time was 20.43 ± 6.19 minutes, and the median return-to-work duration was 2.00 days (mean, 3.03 ± 2.95 d). Patients were followed-up for 18 to 24 months (mean, 22.00 ± 1.88 mo). No serious complications or rehospitalization were observed. No primary failure to heal or recurrence was observed. LIMITATIONS: This study did not include a control group with which to compare and consisted of a relatively small number of patients. CONCLUSIONS: Crystalized phenol treatment combined with endoscopic pilonidal sinus treatment was safe, tolerable, and achieved fast and durable healing with no recurrence over an average of 22 months of follow-up.
[Mh] Termos MeSH primário: Eletrocoagulação/métodos
Endoscopia/métodos
Fenol/uso terapêutico
Seio Pilonidal/terapia
Soluções Esclerosantes/uso terapêutico
[Mh] Termos MeSH secundário: Adulto
Anestesia Local
Estudos de Coortes
Terapia Combinada
Sedação Consciente
Feminino
Seres Humanos
Masculino
Duração da Cirurgia
Dor Pós-Operatória
Readmissão do Paciente
Complicações Pós-Operatórias/epidemiologia
Estudos Prospectivos
Recidiva
Retorno ao Trabalho
Região Sacrococcígea
Resultado do Tratamento
Cicatrização
Adulto Jovem
[Pt] Tipo de publicação:JOURNAL ARTICLE
[Nm] Nome de substância:
0 (Sclerosing Solutions); 339NCG44TV (Phenol)
[Em] Mês de entrada:1704
[Cu] Atualização por classe:170417
[Lr] Data última revisão:
170417
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170308
[St] Status:MEDLINE
[do] DOI:10.1097/DCR.0000000000000778


  10 / 4539 MEDLINE  
              first record previous record
seleciona
para imprimir
Fotocópia
Texto completo
[PMID]:28257672
[Au] Autor:Smith WB; Melton W; Davies J
[Ad] Endereço:Department of Orthopedics, University of South Carolina, 2 Medical Park, Columbia, SC, USA. Electronic address: wbsmithdo@yahoo.com.
[Ti] Título:Midsubstance Tendinopathy, Percutaneous Techniques (Platelet-Rich Plasma, Extracorporeal Shock Wave Therapy, Prolotherapy, Radiofrequency Ablation).
[So] Source:Clin Podiatr Med Surg;34(2):161-174, 2017 Apr.
[Is] ISSN:1558-2302
[Cp] País de publicação:United States
[La] Idioma:eng
[Ab] Resumo:The focus of this article is to present the current options available for noninvasive and percutaneous treatment options for noninsertional Achilles tendinopathy. An attempt is made to offer recommendations for both the treatment techniques as well as postprocedure protocols to be considered. Additionally, because there are numerous treatment options in this category, the different techniques are summarized in a chart format with a short list of pros and cons as well as the levels of evidence in the literature to support the different modalities.
[Mh] Termos MeSH primário: Tendão do Calcâneo/fisiopatologia
Ablação por Cateter/métodos
Ondas de Choque de Alta Energia/uso terapêutico
Plasma Rico em Plaquetas
Escleroterapia/métodos
Tendinopatia/terapia
[Mh] Termos MeSH secundário: Dor Crônica/fisiopatologia
Dor Crônica/terapia
Feminino
Seres Humanos
Injeções Intralesionais
Masculino
Medição da Dor
Soluções Esclerosantes/administração & dosagem
Tendinopatia/diagnóstico
Resultado do Tratamento
[Pt] Tipo de publicação:COMPARATIVE STUDY; JOURNAL ARTICLE; REVIEW
[Nm] Nome de substância:
0 (Sclerosing Solutions)
[Em] Mês de entrada:1711
[Cu] Atualização por classe:171109
[Lr] Data última revisão:
171109
[Sb] Subgrupo de revista:IM
[Da] Data de entrada para processamento:170305
[St] Status:MEDLINE



página 1 de 454 ir para página                         
   


Refinar a pesquisa
  Base de dados : MEDLINE Formulário avançado   

    Pesquisar no campo  
1  
2
3
 
           



Search engine: iAH v2.6 powered by WWWISIS

BIREME/OPAS/OMS - Centro Latino-Americano e do Caribe de Informação em Ciências da Saúde